Cevimeline Hydrochloride Capsule
Product Images NDC 16571-657

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 16571-657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30mg

Label for Cevimeline Hydrochloride Capsules 30 mg oral capsules by Rising Pharma Holdings, Inc., containing 100 capsules. The label includes dosage strength, instructions to dispense with a patient information leaflet, storage directions, and distributor information with barcode and NDC 16571-657-10.*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure of Cevimeline Hydrochloride shown as a molecular diagram including a bicyclic amine structure, an ether linkage, and a methylthioethyl group, with notation indicating the hydrochloride salt and hemihydrate form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.